{
    "organizations": [],
    "uuid": "763b1abcf923bfafa9348a01b3df0c6a48061ce7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-celularity-announces-formation-of/brief-celularity-announces-formation-of-co-with-250-mln-in-funding-from-celgene-united-therapeutics-others-idUSFWN1Q51E2",
    "ord_in_thread": 0,
    "title": "BRIEF-Celularity Announces Formation Of Co With $250 Mln In Funding From Celgene, United Therapeutics, Others",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - Celularity:\n* ‍CELULARITY ANNOUNCES $250 MILLION IN FUNDING TO DELIVER TREATMENTS FOR CANCER, INFLAMMATORY AND DEGENERATIVE DISEASES, AND FUNCTIONAL REGENERATION​\n* CELULARITY SAYS IS ANNOUNCING FORMATION OF CO WITH $250 MILLION IN FUNDING WITH CONTRIBUTIONS FROM CELGENE, UNITED THERAPEUTICS, SORRENTO THERAPEUTICS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-16T01:13:00.000+02:00",
    "crawled": "2018-02-16T17:08:05.098+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "celularity",
        "announces",
        "million",
        "funding",
        "deliver",
        "treatment",
        "cancer",
        "inflammatory",
        "degenerative",
        "disease",
        "functional",
        "celularity",
        "say",
        "announcing",
        "formation",
        "co",
        "million",
        "funding",
        "contribution",
        "celgene",
        "united",
        "therapeutic",
        "sorrento",
        "therapeutic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}